Garry Menzel Insider Profile

4 Followers
Garry Menzel, President & CEO, Director at TCR2 Therapeutics, holds 0.00 shares in TCR2 Therapeutics (Ticker: TCRR), holds 51.83K shares in Black Diamond Therapeutics (Ticker: BDTX), holds ― shares in Stoke Therapeutics (Ticker: STOK).
tipranks
Garry Menzel

Garry Menzel
TCR2 Therapeutics (TCRR)
President & CEO, Director

Not Ranked
Garry Menzel has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$395K
43.20%
41.66%
15.14%
0.00%
0.00% Others
A breakdown of Garry Menzel's holdings

Insider Roles

Black Diamond Therapeutics
(BDTX)
Director
Regulus
(RGLS)
COO & Executive VP, Finance
Adaptimmune Therapeutics
(ADAP)
Director
Stoke Therapeutics
(STOK)
Director
+1 other positions
Roles that Garry Menzel holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Garry Menzel

Garry Menzel's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
TCRR
TCR2 Therapeutics
Jun 01, 2023
Uninformative Sell
$0.00
Black Diamond Therapeutics
Feb 05, 2020
Director
Uninformative Buy
$170.50K
Stoke Therapeutics
Director
Adaptimmune Therapeutics
Jul 10, 2023
Director
Uninformative Sell
43.41K
$59.74K
Regulus
Oct 04, 2012
COO & Executive VP, Finance
Uninformative Buy
$164.41K
DaVita
SVP Finance
$0.00
List of latest transactions for each holding click on a transaction to see Garry Menzel's performance on stock

Garry Menzel insider profile FAQ

What is the percentage of profitable transactions made by Garry Menzel?
The percentage of profitable transactions made by Garry Menzel is ―.
    What is the average return per transaction made by Garry Menzel?
    The average return per transaction made by Garry Menzel is ―.
      What stocks does Garry Menzel hold?
      Garry Menzel holds: TCRR, BDTX, STOK, ADAP, RGLS, DVA stocks.
        What was Garry Menzel’s latest transaction?
        Garry Menzel latest transaction was an Uninformative Sell of ―.
          What was Garry Menzel's most profitable transaction?
          Garry Menzel’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Garry Menzel's role in TCR2 Therapeutics?
            Garry Menzel's role in TCR2 Therapeutics is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.